ACE2 and COVID-19: This study investigated EBV prevalence in plasma and peripheral blood mononuclear cells (PBMCs) of COVID-19 patients using serological (ELISA) and molecular (real-time PCR) methods, while also assessing ACE2 expression levels compared to healthy controls.